Abstract
Major depressive disorder (MDD) is increasingly associated with immune dysregulation, including pro-inflammatory cytokine activity and altered interferon signaling. These systemic changes affect central nervous system function via neuroimmune pathways, contributing to neuroinflammation and mood disturbances. However, the immunomodulatory impact of antidepressants remains unclear. We condu…